WASHINGTON — Almost immediately after beginning his Bethesda, Md., day job as the nation’s top cancer researcher, Ned Sharpless built a roughly 7-mile detour into his weekly routine: a sojourn to the Food and Drug Administration campus for a pickup basketball game.

Whether or not the networking was intentional, Sharpless will soon be spending far more time with the FDA oncologists who once broke his finger. When Scott Gottlieb steps down after a nearly two-year tenure next month, Sharpless will take the helm of that agency, at least in the short term.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The Revolving Door keeps spinning. Chemotherapy Rules. Pharma gets its Trojan Horse moved from the NCI to the FDA. This whole Medical Cartel needs blasting apart. Keep a watchful eye on Gottlieb.

  • Nice that Sharpless is keeping fit with some of his staffers, but what is he doing to network with female staffers, most of whom won’t play pickup basketball, I assume??

  • The NCI could get a real director now, the FDA will continue the war against tobacco. The cancer patients always loose..

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy